Title:
【発明の名称】シグマ2選択性リガンドである新規アルキルアミノ誘導体
Document Type and Number:
Japanese Patent JPH10508826
Kind Code:
A
Abstract:
The present invention relates to novel alkylamino derivatives of formula (I). These compounds exhibit a high selectivity and a high affinity for sigma 2 receptor and therefore are useful in the treatment of central nervous system disorders as well as other disorders modulated by this receptor.
Inventors:
Roche Jean-Philippe
Application Number:
JP50719496A
Publication Date:
September 02, 1998
Filing Date:
August 10, 1995
Export Citation:
Assignee:
Mitsubishi Chemical Corporation
International Classes:
C07D275/04; A61K31/41; A61K31/425; A61K31/428; A61K31/433; A61K31/495; A61K31/535; A61K31/54; A61K31/5415; A61K31/55; A61K31/554; A61P9/00; A61P25/00; A61P25/04; A61P25/24; A61P25/26; A61P43/00; C07D221/12; C07D267/20; C07D275/06; C07D279/02; C07D279/26; C07D279/28; C07D279/34; C07D281/16; C07D285/14; C07D285/16; C07D401/06; C07D401/12; C07D413/06; C07D417/06; (IPC1-7): C07D417/06; A61K31/41; A61K31/425; A61K31/495; A61K31/535; A61K31/54; A61K31/55; C07D275/04; C07D279/02; C07D279/26; C07D279/28; C07D279/34; C07D281/16; C07D285/14; C07D285/16; C07D401/06
Attorney, Agent or Firm:
Masazumi Imamura (1 person outside)